Summary Chapter 8 CHAPTER 8. Summary. Page 173

Similar documents
Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Measuring Lipid Composition LC-MS/MS

Analysis of Limonin in Citrus Juice Using QuEChERS and LC-MS/MS

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Exploring Changes in Primary Metabolites in Alzheimer s Disease using Targeted LC-MS/MS

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Determination of Clarithromycin in Human Plasma by LC-EI Tandem Mass Spectrometry: Application to Bioequivalence Study

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Determination of Glimepiride in Human Plasma by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Identification of Steroids in Water by Ion Trap LC/MS/MS Application

Gradient Elution LC-MS/MS Determination of Gefitinib in Rat Plasma and its Pharmacokinetic Study

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Application Note. Author. Abstract. Introduction. Food Safety

Simultaneous Determination and Pharmacokinetic Study of Metformin and Rosiglitazone in Human Plasma by HPLC ESI-MS

Research Article. Liquid-liquid extraction method for Ziprasidone (ZRS) bioanalysis by using ZRS-D 8 (stable isotope) as internal standard

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

application Natural Food Colorants Analysis of Natural Food Colorants by Electrospray and Atmospheric Pressure Chemical Ionization LC/MS

CHAPTER 3.1 BIOANALYSIS OF RIVASTIGMINE

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

The Comparison of High Resolution MS with Triple Quadrupole MS for the Analysis of Oligonucleotides

Designer Cannabinoids

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Polymer Additive Analysis by EI and APCI

Matrix-induced Signal Enhancement of Propamocarb in LC-MS/MS

Vitamin D3 and related compounds by ESI and APCI

Neosolaniol. [Methods listed in the Feed Analysis Standards]

CHAPTER 4 Cremophor-EL LC-MS/MS

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Abstract. Introduction

Uptake and Metabolism of Phthalate Esters by Edible Plants

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Application Note. Abstract. Authors. Pharmaceutical

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Determination of 44 Pesticides in Foodstuffs by LC/MS/MS Application

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Analytical Challenges in Veterinary Toxicology: Bromethalin

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Key Advantages of Comprehensive Cannabis Analysis

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

Determination of Amantadine Residues in Chicken by LCMS-8040

Characterization of an Unknown Compound Using the LTQ Orbitrap

Overview of Matrix Effects in Bioanalysis

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Maria João Mendes Mendonça Barreira Department of Health Promotion and Chronic Deseases, INSA

High Throughput simultaneous analysis of 39 amino acids in various foods without derivatization using LC-MS/MS

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

LC-MS/MS Method for the Determination of Raloxifene and its Glucuronide Metabolites from Human Plasma Using SPE Micro Elution

The Raptor HILIC-Si Column

LC-MS/MS Method for the Determination of Tenofovir from Plasma

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Ion Source. Mass Analyzer. Detector. intensity. mass/charge

Rapid and Sensitive Determination of Timosaponin AIII in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Application

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Comparison of Full Scan MS2 and MS3 Linear Ion Trap Approaches for Quantitation of Vitamin D

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Fig. 1: Chemical structure of arachidonic acid COOH CH 3

Chapter-4. The reference/working standards used were from Manipal acunova reference standards Bank.

Pharmacologyonline 1: (2010) Newsletter Mohan et al.

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

PHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES. DR. A. RAMESH, Ph.D, D.Sc.,

Impact of Reversed-Phase Chiral Chromatography on the LC-MS Analysis of Drugs in Biological Fluids

Quantitative Detection of Ambroxol in Human Plasma Using HPLC-APCI-MS/MS: Application to a Pharmacokinetic Study

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

Application Note # LCMS-89 High quantification efficiency in plasma targeted proteomics with a full-capability discovery Q-TOF platform

Sample Preparation is Key

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

CONTENT. i iv ix. SVKM s NMIMS, School of Pharmacy and Technology Management

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Determination of N-Nitrososarcosine (NSAR) in tobacco

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Unique Retention and Selectivity of Pentafluorophenylpropyl Phases for High-Throughput LC/MS Analysis

Method Validation for the Analysis of Multiple Weight Loss Drugs in Dietary Supplement Materials by LC-MS/MS

Dienes Derivatization MaxSpec Kit

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Development of a High Sensitivity SPE-LC-MS/MS Assay for the Quantification of Glucagon in Human Plasma Using the ionkey/ms System

Authors. Abstract. Introduction. Environmental

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Transcription:

CHAPTER 8 Summary Page 173

Chapter 2: Liquid Chromatography/Tandem Mass Spectrometry Method for Quantitative Estimation of PEG 400 and its Applications A rapid sensitive and selective MRM based method for the determination of polyethylene glycol 400 (PEG 400) in rat plasma was developed using liquid chromatography/tandem mass (LC-MS/MS). PEG 400 and telmisartan (internal standard) were extracted from rat plasma with acetonitrile and analyzed on C18 column (Waters Xbridge, 50 x 4.6 mm, 3.5µm) with the mobile phase (A-0.1% formic acid in water; B-methanol). A generic gradient method with a short run time of 3.5 min was developed for the analysis of PEG 400. A total of nine oligomers were identified for PEG 400. The most abundant ions corresponding to PEG 400 oligomers at m/z 327, 371, 432, 476, 520, 564, 608, 652 and 696 with daughter ion at m/z 89 were selected for multiple reaction monitoring (MRM) in electrospray mode of ionisation. Analyte peak area of the oligomers was summed up to calculate the plasma concentrations of total PEG 400. The standard curve was linear (0.9954) over the concentration range of 1.01 to 1013.40 µg/ml. The developed method was successfully applied to the absolute bioavailability study of PEG 400 in male SD rats. Plasma concentrations of PEG 400 were measured after administration through oral and intravenous routes in male SD rats at a dose of 3.38 g/kg. Pharmacokinetic (PK) parameters were characterized by performing the analysis using Phoenix Winnonlin software (v 6.3). Plasma concentration profile/pk parameters of PEG 400 were established in both intravenous and oral routes, which help to qualify the analytical batch of NCEs having spiky plasma concentration profiles/erratic results. Purity of the PEG 400 oligomers was estimated using ELSD detection. Differences in pharmacokinetics of oligomers were studied. It was found that with increase in molecular weight of the oligomer, a decrease in absolute bioavailability was observed. Page 174

Chapter 3: Identification and Reduction of Matrix Effects caused by PEG 400 in bioanalysis using Liquid chromatography/tandem mass Ion suppression effect of dosing vehicle excipient polyethyleneglycol 400 on the accuracy of liquid chromatography/tandem mass (LC-MS/MS) measurements was studied. Ion suppression cause significant errors in accuracy of the pharmacokinetic results. Plasma concentrations of PEG 400 ranging from 3-10 mg/ml in the initial sampling points caused 2-10 fold ion supression on most of the analytes studied. This can result in false rejection of compounds in a drug discovery screen. Several sample preparation methods, enhanced chromatographic selectivity, and alternative ionization methods were investigated as means to avoid or minimize ion suppression effects. The elimination of ion suppression effects was achieved by liquid liquid Extraction (LLE) with hexane as sample preparation method. The mechanism of ion suppression caused by polyethylene glycol 400 in relation to both liquid and gas phase reactions was proposed. Chapter 4: Liquid chromatography/tandem Mass Spectrometry Method for the Quantitative Estimation of CrEL and its Applications A rapid sensitive and selective MRM based method for the determination of Cremophor EL (CrEL) in rat plasma was developed using liquid chromatography/tandem mass (LC-MS/MS). CrEL and polypropylene glycol (internal standard) were extracted from rat plasma with acetonitrile and analysed on C18 column (XBridge, 50 x 4.6 mm, 3.5 µm) with the mobile phase (A- 0.1 % formic acid in water; B- acetonitrile with 20% tetrahydrofuran). A generic gradient method with a short run time of 3.5 min was developed for the analysis of CrEL. The most abundant molecular ions corresponding to PEG oligomers at m/z 828, 872, 916 and 960 with daughter ion at m/z 89 were selected for multiple reaction monitoring (MRM) in electrospray mode of ionisation. Plasma concentrations of CrEL were quantified after administration through oral and intravenous routes in male sprague dawley rats at a dose of 0.26 g/kg. The standard curve was linear (0.9972) over the concentration range of 1.00 to 200 µg/ml. Pharmacokinetic parameters were Page 175

characterized by performing the analysis using phoenix winnonlin software (v 6.3). Plasma concentration profile/pk parameters of CrEL in male sprague dawley rats was established in both intravenous and oral routes, which help to qualify the analytical batch of NCEs having spiky plasma concentration profiles/erratic results. Chapter 5: Identification and Reduction of Matrix Effects caused by CrEL in bioanalysis using Liquid chromatography/tandem mass Ion suppression effect of dosing vehicle excipient Cremophor EL (CrEL) on the accuracy of liquid chromatography/tandem mass (LC-MS/MS) measurements was studied. Ion supression cause significant errors in accuracy of the pharmacokinetic results. Plasma concentrations of CrEL ranging from 0.50-1.0 mg/ml in the initial sampling points caused 2-10 fold ion supression on most of the analytes studied. This can result in false rejection of compounds in a drug discovery screen. Various sample preparation methods, enhanced chromatographic selectivity, and alternative ionization methods were investigated as means to avoid or minimize ion suppression effects. The elimination of ion suppression effects was achieved by Liquid-Liquid Extraction (LLE) with hexane, TBME in electrospray ionisation (ESI) mode as sample preparation method. In contrast to ESI mode that had severe suppression effects from CrEL, atmospheric pressure chemical ionisation (APCI) mode is totally free of suppression effects. The mechanism of ion suppression caused by CrEL in relation to both liquid and gas phase reactions was proposed. Chapter 6: Liquid chromatography/tandem Mass Spectrometry Method for the Quantitative Estimation of Solutol HS15 and its Applications A rapid sensitive and selective pseudomrm (pmrm) based method for the determination of solutol HS15 (SHS15) in rat plasma was developed using liquid chromatography/tandem mass (LC-MS/MS). SHS 15 and telmisartan (internal standard) were extracted from rat plasma with acetonitrile and analysed on C18 column (Thermo, 50 x 4.6 mm, 2.5 µm) with the mobile phase (A-0.1 % formic acid in water; B- Acetone). A generic gradient method with a short run time of 5 min was developed for the analysis of SHS15. The most abundant ions corresponding to Page 176

SHS15 free polyethyleneglycol (PEG) oligomers at m/z 481, 525, 569, 613, 657, 701, 745, 789, 833, 877, 921 and 965 were selected for pseudo multiple reaction monitoring (pmrm) in electrospray mode of ionisation. Purity of the lipophilic and hydrophilic components of SHS15 was estimated using ELSD detector. Plasma concentrations of SHS15 were measured after oral administration at 2.50 g/kg dose and intravenous administration at 1.00 g/kg dose in male SD rats. The standard curve was linear (0.9978) over the concentration range of 0.40 to 185.90 µg/ml. Pharmacokinetic parameters were characterized by performing the analysis using phoenix winnonlin software (v 6.3). Differences in pharmacokinetics of oligomers were studied. With the increase in molecular weight of the oligomer, a decrease in absolute bioavailability was observed. Plasma concentration profile/pk parameters of SHS15 in male sprague dawley rats was established in both intravenous and oral routes, which help to qualify the analytical batch of NCEs having spiky plasma concentration profiles/erratic results. Chapter 7: Identification and Reduction of Matrix Effects caused by SHS 15 in bioanalysis using Liquid chromatography/tandem mass Ion suppression effect of dosing vehicle excipient Solutol HS15 (SHS15) on the accuracy of liquid chromatography/tandem mass (LC-MS/MS) measurements was studied. Ion supression cause significant errors in accuracy of the pharmacokinetic results. Plasma concentrations of SHS15 ranging from 1-2 mg/ml in the initial sampling points caused 2-10 fold ion supression on most of the analytes studied. This can result in false rejection of compounds in a drug discovery screen. Several sample preparation methods, enhanced chromatographic selectivity, and alternative ionization methods were investigated as means to avoid or minimize ion suppression effects. The elimination of ion suppression effects was achieved by Liquid-Liquid Extraction (LLE) with hexane, tert-butyl-methyl ether (TBME) as sample preparation method. The mechanism of ion suppression caused by SHS15 in relation to both liquid and gas phase reactions was proposed. Page 177